{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:02:25Z","timestamp":1794081745620,"version":"4.8.0"},"reference-count":54,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"1","content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["biomedica"],"abstract":"<jats:p>En Colombia, especialmente en las unidades de cuidados intensivos, la candidemia es una causa frecuente de infecci\u00f3n del torrente sangu\u00edneo y representa el 88 % de lasinfecciones f\u00fangicas en pacientes hospitalizados, con una mortalidad entre 36 y 78 %. Su incidencia en Colombia es mayor a la reportada en los pa\u00edses desarrollados e, incluso, en otros pa\u00edses de Latinoam\u00e9rica. Para su manejo deben considerarse los factores de riesgo del paciente, luego valorar las caracter\u00edsticas cl\u00ednicas y, finalmente, hacer los estudios microbiol\u00f3gicos y, si es necesario, pruebas moleculares.En general, las gu\u00edas estadounidenses, latinoamericanas y europeas recomiendan las equinocandinas como el tratamiento de primera l\u00ednea de la candidemia y difieren en el uso de fluconazol dependiendo de la \u2018evidencia\u2019, la gravedad de la enfermedad, la exposici\u00f3n previa a los azoles y la prevalencia de Candida no albicans. Dada su gran incidencia en nuestro pa\u00eds, asociada con una elevada mortalidad, esta infecci\u00f3n debe buscarse sistem\u00e1ticamente en pacientes con factores de riesgo, con el fin de iniciar oportunamente el tratamiento antif\u00fangico.\r\n\u00a0<\/jats:p>","DOI":"10.7705\/biomedica.4400","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T15:56:37Z","timestamp":1584633397000},"page":"195-207","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":37,"title":["Candidemia en Colombia"],"prefix":"10.7705","volume":"40","author":[{"given":"Jorge Alberto","family":"Cort\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Franklin","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizeth Natalia","family":"Melgarejo-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elkin V.","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4444","published-online":{"date-parts":[[2020,3,1]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Cort\u00e9s JA, Reyes P, G\u00f3mez CH, Cuervo SI, Rivas P, Casas CA, et al. Clinical and epidemiological characteristics and risk factors for mortality in patients with candidemia in hospitals from Bogot\u00e1, Colombia. Braz J Infect Dis. 2014;18:631-7. https:\/\/doi.org\/10.1016\/j.bjid.2014.06.009","DOI":"10.1016\/j.bjid.2014.06.009"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Nucci M, Thompson-Moya L, Guzm\u00e1n-Blanco M, Tiraboschi IN, Cort\u00e9s JA, Echevarr\u00eda J, et al. Recommendations for the management of candidemia in adults in Latin America. Latin America Invasive Mycosis Network. Rev Iberoam Micol. 2013;30:179-88. https:\/\/doi.org\/10.1016\/j.riam.2013.05.007","DOI":"10.1016\/j.riam.2013.05.007"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Zuluaga-Rodr\u00edguez A, De Bedout-G\u00f3mez C, Agudelo-Restrepo C, Hurtado-Parra H, Arango-Arteaga M, Restrepo-Moreno A, et al. Sensibilidad a fluconazol y voriconazol de especies de Candida aisladas de pacientes provenientes de unidades de cuidados intensivos en Medell\u00edn, Colombia (2001-2007). Rev Iberoam Micol. 2010;27:125-9. https:\/\/doi.org\/10.1016\/j.riam.2010.04.001","DOI":"10.1016\/j.riam.2010.04.001"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Cort\u00e9s JA, Reyes P, G\u00f3mez C, Buitrago G, Leal AL y Group G. Fungal bloodstream infections in tertiary care hospitals in Colombia. Rev Iberoam Micol. 2011;28:74-8. https:\/\/doi.org\/10.1016\/j.riam.2010.12.002","DOI":"10.1016\/j.riam.2010.12.002"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cort\u00e9s J, Zurita J, et al. Epidemiology of candidemia in Latin America: A laboratory-based survey. PLoS ONE. 2013;8:e59373. https:\/\/doi.org\/10.1371\/journal.pone.0059373","DOI":"10.1371\/journal.pone.0059373"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Berr\u00edo I, Maldonado N, De Bedout C, Arango K, Cano LE, Valencia Y, et al. Comparative study of Candida spp. isolates: Identification and echinocandin susceptibility in isolates obtained from blood cultures in 15 hospitals in Medell\u00edn, Colombia. J Glob Antimicrob Resist. 2018;13:254-60. https:\/\/doi.org\/10.1016\/j.jgar.2017.11.010","DOI":"10.1016\/j.jgar.2017.11.010"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Paramythiotou E, Frantzeskaki F, Flevari A, Armaganidis A, Dimopoulos G. Invasive fungal infections in the ICU: How to approach, how to treat. Molecules. 2014;19:1085-119. https:\/\/doi.org\/10.3390\/molecules19011085","DOI":"10.3390\/molecules19011085"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Scudeller L, Viscoli C, Menichetti F, del Bono V, Cristini F, Tascini C, et al. An Italian consensus for invasive candidiasis management (ITALIC). Infection. 2014;42:263-79. https:\/\/doi.org\/10.1007\/s15010-013-0558-0","DOI":"10.1007\/s15010-013-0558-0"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Eggimann P, Garbino J, Pittet D. Management of Candida species infections in critically ill patients. Lancet Infect Dis. 2003;3:772-85. https:\/\/doi.org\/10.1016\/S1473-3099(03)00831-4","DOI":"10.1016\/S1473-3099(03)00831-4"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Cort\u00e9s JA, Corrales IF. Invasive candidiasis: Epidemiology and risk factors in fungal infection. Londres: Intech Open; 2019:33-46. https:\/\/doi.org\/10.5772\/intechopen.81813","DOI":"10.5772\/intechopen.81813"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Ortiz-Ruiz G, Osorio J, Valderrama S, \u00c1lvarez D, Elias-D\u00edaz R, Calder\u00f3n J, et al. Risk factors for candidemia in non-neutropenic critical patients in Colombia. Med Intensiva. 2016;40:139-44. https:\/\/doi.org\/10.1016\/j.medin.2015.08.001","DOI":"10.1016\/j.medin.2015.08.001"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"De Bedout C, G\u00f3mez B. Candida y candidiasis invasora: un reto continuo para su diagn\u00f3stico temprano. Infectio. 2010;14:s159-71. https:\/\/doi.org\/10.1016\/S0123-9392(10)70133-8","DOI":"10.1016\/S0123-9392(10)70133-8"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Orozco P, Cort\u00e9s J, Parra C. Colonizaci\u00f3n por levaduras en reci\u00e9n nacidos y personal de salud en la unidad de cuidados intensivos neonatales de un hospital universitario en Bogot\u00e1, Colombia. Rev Iberoam Micol. 2009;26:108-11 https:\/\/doi.org\/10.1016\/S1130-1406(09)70020-8","DOI":"10.1016\/S1130-1406(09)70020-8"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1590\/S1413-86702008000500009","article-title":"bloodstream infection in a tertiary care center in Bogot\u00e1, Colombia","volume":"12","author":"D\u00edaz-Granados","year":"2008","unstructured":"D\u00edaz-Granados CA, Mart\u00ednez A, Deaza C, Valderrama S. An outbreak of Candida spp. bloodstream infection in a tertiary care center in Bogot\u00e1, Colombia. Braz J Infect Dis. 2008;12:390-4.","journal-title":"Braz J Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Asmundsdottir LR, Erlendsdottir H, Haraldsson G, Guo H, Xu J, Gottfredsson M. Molecular epidemiology of candidemia: Evidence of clusters of smoldering nosocomial infections. Clin Infect Dis. 2008;47:e17-24. https:\/\/doi.org\/10.1086\/589298","DOI":"10.1086\/589298"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Desai JV, Mitchell AP. Candida albicans biofilm development and its genetic control. Microbiol Spectr. 2015;3(3):MB-0005-2014. https:\/\/doi.org\/10.1128\/microbiolspec.MB-0005-2014","DOI":"10.1128\/microbiolspec.MB-0005-2014"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Cort\u00e9s JA, Jaimes JA, Leal AL. Incidencia y prevalencia de candidemia en pacientes cr\u00edticamente enfermos en Colombia. Rev Chil Infectol. 2013;30:599-604. https:\/\/doi.org\/10.4067\/S0716-10182013000600004","DOI":"10.4067\/S0716-10182013000600004"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64:134-40. https:\/\/doi.org\/10.1093\/cid\/ciw691","DOI":"10.1093\/cid\/ciw691"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Parra-Giraldo CM, Valderrama SL, Cort\u00e9s-Fraile G, Garz\u00f3n JR, Ariza BE, Morio F, et al. First report of sporadic cases of Candida auris in Colombia. Int J Infect Dis. 2018;69:63-7. https:\/\/doi.org\/10.1016\/j.ijid.2018.01.034","DOI":"10.1016\/j.ijid.2018.01.034"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Escand\u00f3n P, Chow NA, C\u00e1ceres DH, Gade L, Berkow EL, Armstrong P, et al. Molecular epidemiology of Candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance. Clin Infect Dis. 2019;68:15-21. https:\/\/doi.org\/10.1093\/cid\/ciy411","DOI":"10.1093\/cid\/ciy411"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Morales-L\u00f3pez SE, Parra-Giraldo CM, Ceballos-Garz\u00f3n A, Mart\u00ednez HP, Rodr\u00edguez GJ, \u00c1lvarez-Moreno CA, et al. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis. 2017;23:162-4. https:\/\/doi.org\/10.3201\/eid2301.161497","DOI":"10.3201\/eid2301.161497"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Motoa G, Mu\u00f1oz JS, O\u00f1ate J, Pallares CJ, Hern\u00e1ndez C, Villegas MV. Epidemiology of Candida isolates from intensive care units in Colombia from 2010 to 2013. Rev Iberoam Micol. 2017;34:17-22. https:\/\/doi.org\/10.1016\/j.riam.2016.02.006","DOI":"10.1016\/j.riam.2016.02.006"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Thomaz DY, de Almeida JN Jr, Lima GM, Nunes MO, Camargo CH, Grenfell RC, et al. An azole-resistant Candida parapsilosis outbreak: clonal persistence in the intensive care unit of a Brazilian teaching hospital. Front Microbiol. 2018;9:2997. https:\/\/doi.org\/10.3389\/fmicb.2018.02997","DOI":"10.3389\/fmicb.2018.02997"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Cort\u00e9s JA, Prada G. Protocolo de estudio y manejo de pacientes con candidiasis sist\u00e9mica en adultos. Infectio. 2012;16:118-22. https:\/\/doi.org\/10.1016\/S0123-9392(12)70037-1","DOI":"10.1016\/S0123-9392(12)70037-1"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Ahmadi A, Ardehali SH, Beigmohammadi MT, Hajiabdolbaghi M, Hashemian SM, Kouchek M, et al. Invasive candidiasis in intensive care unit; consensus statement from an Iranian panel of experts, July 2013. JRSM Open. 2014;5:2042533313517689. https:\/\/doi.org\/10.1177\/2042533313517689","DOI":"10.1177\/2042533313517689"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503-35. https:\/\/doi.org\/10.1086\/596757","DOI":"10.1086\/596757"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"D\u00edaz J, Urrego J, Moreno J, Hu\u00e9rfano C, Prieto V. An\u00e1lisis de costo-efectividad de anidulafungina en el tratamiento de la candidiasis invasiva en Colombia. Value Health. 2015;18:A870. https:\/\/doi.org\/10.1016\/j.jval.2015.09.010","DOI":"10.1016\/j.jval.2015.09.010"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Kami M, Machida U, Okuzumi K, Matsumura T, Mori Si S, Hori A, et al. Effect of fluconazole prophylaxis on fungal blood cultures: An autopsy-based study involving 720 patients with haematological malignancy. Br J Haematol. 2002;117:40-6. https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03414.x","DOI":"10.1046\/j.1365-2141.2002.03414.x"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: Non-neutropenic adult patients. Clin Microbiol Infect. 2012;18(Suppl.7):19-37. https:\/\/doi.org\/10.1111\/1469-0691.12039","DOI":"10.1111\/1469-0691.12039"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Le\u00f3n C, Ruiz-Santana S, Saavedra P, Galv\u00e1n B, Blanco A, Castro C, et al. Usefulness of the \"Candida score\" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study. Crit Care Med. 2009;37:1624-33. https:\/\/doi.org\/10.1097\/CCM.0b013e31819daa14","DOI":"10.1097\/CCM.0b013e31819daa14"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, V\u00e1zquez JA, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: A clinical trial. Clin Infect Dis. 2015;60:892-9. https:\/\/doi.org\/10.1093\/cid\/ciu959","DOI":"10.1093\/cid\/ciu959"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Berdal JE, Haagensen R, Ranheim T, Bjornholt JV. Nosocomial candidemia; risk factors and prognosis revisited; 11 years experience from a Norwegian secondary hospital. PLoS ONE. 2014;9:e103916. https:\/\/doi.org\/10.1371\/journal.pone.0103916","DOI":"10.1371\/journal.pone.0103916"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study. Clin Infect Dis. 2006;43:25-31. https:\/\/doi.org\/10.1086\/504810","DOI":"10.1086\/504810"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Aguado JM, Ruiz-Camps I, Mu\u00f1oz P, Mensa J, Almirante B, V\u00e1zquez L, et al. Recomendaciones sobre el tratamiento de la candidiasis invasiva y otras infecciones por levaduras de la Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica (SEIMC). Actualizaci\u00f3n 2011. Enferm Infecc Microbiol Clin. 2011;29:345-61. https:\/\/doi.org\/10.1016\/j.eimc.2011.01.008","DOI":"10.1016\/j.eimc.2011.01.008"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Kullberg BJ, Verweij PE, Akova M, Arendrup MC, Bille J, Calandra T, et al. European expert opinion on the management of invasive candidiasis in adults. Clin Microbiol Infect. 2011;17(Suppl.5):1-12. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03615.x","DOI":"10.1111\/j.1469-0691.2011.03615.x"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-Adri\u00e1n LJ, King RT, Tamayo-Derat LG, Miller JW, Garc\u00eda CA, Rex JH. Retinal lesions as clues to disseminated bacterial and candidal infections: Frequency, natural history, and etiology. Medicine (Baltimore). 2003;82:187-202. https:\/\/doi.org\/10.1097\/01.md.0000076008.64510.f1","DOI":"10.1097\/01.md.0000076008.64510.f1"},{"key":"ref36","unstructured":"Centers for Disease Control and Prevention. Invasive candidiasis. Fecha de consulta: 31 marzo de 2018. Disponible en: https:\/\/www.cdc.gov\/fungal\/diseases\/candidiasis\/invasive\/index.html"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1-50. https:\/\/doi.org\/10.1093\/cid\/civ933","DOI":"10.1093\/cid\/civ933"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.22354\/in.v23i3.792","article-title":"disease in children and adults","volume":"23","author":"O\u00f1ate","year":"2019","unstructured":"O\u00f1ate J, Rivas J, Pallares C, Saavedra C, Mart\u00ednez E, Coronell W, et al. Colombian consensus on the diagnosis, treatment, and prevention of Candida spp. disease in children and adults. Infectio. 2019;23:271-304.","journal-title":"Infectio"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Cort\u00e9s JA, Russi JA. Equinocandinas. Rev Chil Infectol. 2011;28:529-36. https:\/\/doi.org\/10.4067\/S0716-10182011000700004","DOI":"10.4067\/S0716-10182011000700004"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Marcos-Zambrano LJ, G\u00f3mez-Perosanz M, Escribano P, Zaragoza O, Bouza E, Guinea J. Biofilm production and antibiofilm activity of echinocandins and liposomal amphotericin B in echinocandin-resistant yeast species. Antimicrob Agents Chemother. 2016;60:3579-86. https:\/\/doi.org\/10.1128\/AAC.03065-15","DOI":"10.1128\/AAC.03065-15"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Marcos-Zambrano LJ, Escribano P, Bouza E, Guinea J. Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilms. J Antimicrob Chemother. 2016;71:2498-501. https:\/\/doi.org\/10.1093\/jac\/dkw162","DOI":"10.1093\/jac\/dkw162"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Colombo AL, Guimaraes T, Camargo LF, Richtmann R, Queiroz-Telles F, Salles MJ, et al. Brazilian guidelines for the management of candidiasis - a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical. Braz J Infect Dis. 2013;17:283-312.https:\/\/doi.org\/10.1016\/j.bjid.2013.02.001","DOI":"10.1016\/j.bjid.2013.02.001"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Auzinger G, Playford EG, Graham CN, Knox HN, Weinstein D, Kantecki M, et al. Costeffectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis. BMC Infect Dis. 2015;15:463. https:\/\/doi.org\/10.1186\/s12879-015-1143-1","DOI":"10.1186\/s12879-015-1143-1"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: A patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54:1110-22. https:\/\/doi.org\/10.1093\/cid\/cis021","DOI":"10.1093\/cid\/cis021"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, et al. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis. 2007;45:883-93. https:\/\/doi.org\/10.1086\/520980","DOI":"10.1086\/520980"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Kubiak DW, Bryar JM, McDonnell AM, Delgado-Flores JO, Mui E, Baden LR, et al. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: A retrospective, observational, sequential cohort analysis. Clin Ther. 2010;32:637-48. https:\/\/doi.org\/10.1016\/j.clinthera.2010.04.005","DOI":"10.1016\/j.clinthera.2010.04.005"},{"key":"ref47","unstructured":"Yan T, Li SL, Wang DX. Comparison between micafungin and caspofungin for the empirical treatment of severe intra-abdominal infections in surgical intensive care patients. Zhonghua Yi Xue Za Zhi. 2016;96:2301-6. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2016.29.004"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Botero MC, Puentes-Herrera M, Cort\u00e9s JA. Formas lip\u00eddicas de anfotericina. Rev Chil Infectol. 2014;31:518-27. https:\/\/doi.org\/10.4067\/S0716-10182014000500002","DOI":"10.4067\/S0716-10182014000500002"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Cort\u00e9s JA, Soto R, \u00c3lvarez CA, Buitrago G, Camargo RD, Cata\u00f1o JC, et al. Consenso de uso de antimicrobianos en pacientes cr\u00edticamente enfermos con falla renal o en riesgo de padecerla. Infectio. 2011;15:49-63. https:\/\/doi.org\/10.1016\/S0123-9392(11)70076-5","DOI":"10.1016\/S0123-9392(11)70076-5"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Reboli AC, Rotstein C, Pappas PG, Chapman SW, Kett DH, Kumar D, et al. Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med. 2007;356:2472-82. https:\/\/doi.org\/10.1056\/NEJMoa066906","DOI":"10.1056\/NEJMoa066906"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Wang JL, Chang CH, Young-Xu Y, Chan KA. Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection. Antimicrob Agents Chemother. 2010;54:2409-19. https:\/\/doi.org\/10.1128\/AAC.01657-09","DOI":"10.1128\/AAC.01657-09"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Maldonado NA, Cano LE, De Bedout C, Arbel\u00e1ez CA, Roncancio G, Tabares AM, et al. Association of clinical and demographic factors in invasive candidiasis caused by fluconazoleresistant Candida species: A study in 15 hospitals, Medell\u00edn, Colombia 2010-2011. Diagn Microbiol Infect Dis. 2014;79:280-6. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.02.003","DOI":"10.1016\/j.diagmicrobio.2014.02.003"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-Leguizam\u00f3n G, Fiori A, Lagrou K, Gaona MA, Iba\u00f1\u00e9z M, Patarroyo MA, et al. New echinocandin susceptibility patterns for nosocomial Candida albicans in Bogota, Colombia, in ten tertiary care centres: An observational study. BMC Infect Dis. 2015;15:108. https:\/\/doi.org\/10.1186\/s12879-015-0840-0","DOI":"10.1186\/s12879-015-0840-0"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/4400\/4350","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/4400\/4350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T16:21:56Z","timestamp":1598286116000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/4400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.4400","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,1]]},"assertion":[{"value":"2020-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Topic review","name":"content_type","label":"Content Type"}]}}